Application of exosome engineering modification in targeted delivery of therapeutic drugs

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapeutics

Background:

• Cancer remains a leading cause of mortality, necessitating improved therapeutic strategies.
• Conventional cancer drugs often lack tumor specificity, leading to severe toxicity and limited efficacy.
• Effective drug delivery systems are crucial for enhancing the therapeutic index of anticancer agents.

Purpose of the Study:

• To review the properties and biogenesis of exosomes as natural drug delivery vehicles.
• To explore methods for engineering exosomes to improve their utility in cancer therapy.
• To highlight the potential of exosomes in overcoming challenges in current cancer drug delivery.

Main Methods:

• Review of existing literature on exosome biology and engineering.
• Analysis of exosome characteristics relevant to drug delivery (e.g., size, surface markers, stability).
• Summarization of exosome biogenesis pathways and engineering strategies for yield, targeting, and drug loading.

Main Results:

• Exosomes possess inherent properties like low immunogenicity and prolonged circulation, making them suitable natural nanocarriers.
• Exosome engineering can significantly enhance their drug-loading capacity and tumor-targeting efficiency.
• Modified exosomes offer a promising platform for targeted delivery of anticancer drugs, potentially minimizing systemic toxicity.

Conclusions:

• Exosomes represent a viable and advantageous platform for advanced cancer drug delivery systems.
• Engineering exosomes provides a powerful approach to optimize their therapeutic potential in oncology.
• Further research into exosome-based therapies could revolutionize cancer treatment paradigms.